Dieckol, a phlorotannin of Ecklonia cava, suppresses IgE-mediated mast cell activation and passive cutaneous anaphylactic reaction
Dieckol, a phlorotannin of Ecklonia cava, suppresses IgE-mediated mast cell activation and passive cutaneous anaphylactic reaction
复制标题
DOI:
10.1111/exd.12814
复制
发表时间:
2015-12-01
影响因子:
3.6
通讯作者:
Tanaka, Akane
中科院分区:
文献类型:
--
作者:
Ahn, Ginnae;Amagai, Yosuke;Tanaka, Akane
BackgroundMast cell activation mediated by immunoglobulin E (IgE) plays a crucial role in allergic diseases related to type I hypersensitivity including allergic rhinitis, asthma and atopic dermatitis (1, S1, S2). Binding of IgE to FceRI receptors, followed by the cross-linkage of the IgE with the antigen, leads to the mast cell activation and secretion of preformed chemical mediators such as lipid mediators (leukotrienes and prostaglandins), granular contents (b-hexosaminidase and histamine), and inflammatory cytokines (interleukin [IL]-4, IL-6, IL-13, and tumor necrosis factor [TNF]-a), which initiates and exacerbates allergic inflammation (2, 3, S3-6). Thus, stabilization of mast cells or blocking the released mediators’ action is a major strategy for the treatment of patients with type I hypersensitivity. While several agents such as non-steroidal anti-inflammatory drugs, steroids and immunosuppressants have been used, they more or less bring about adverse effects (4, S7). Therefore, safe candidates with both anti-allergic property and less toxicity have been expected. Recent studies have suggested that phlorotannins, which were extracted from the brown seaweed Ecklonia cava, have an inhibitory effect on FceRI expression on basophils and IgE-mediated granule release (5, S8). Another experiment determined a dieckol, one of the active ingredients from the extract, exerted potent anti-inflammatory effects by abrogating cyclooxygenase-2 (COX2) and inducible nitric oxide synthase (iNOS) activation (6).